| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |